Home | Business News | Browse by Publication | M | Medical Letter on the CDC & FDA

The End of the Bio-Identical Hormone Debate.

Publication: Medical Letter on the CDC & FDA
Publication Date: 27-SEP-09
Format: Online
Delivery: Immediate Online Access

Article Excerpt
Life Extension , the company that long ago sounded the alarm on the dangers of synthetic hormone replacement therapy for menopausal women, has published still more proof that bioidentical hormones offer a far safer treatment option (see also Hormones).

A white paper entitled Bioidentical Hormones: Why Is There Still a...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from Medical Letter on the CDC & FDA
New Study Finds Links Between Video-Game Playing and Health Risks in A..., September 27, 2009
New multiple sclerosis data have been reported by researchers at Unive..., September 27, 2009
New research on sensorineural hearing loss from P.T. Maddox and co-aut..., September 27, 2009
Original Research Using Vicor Technologies' PD2i Algorithm Published i..., September 27, 2009
Research results from University of Freiburg update knowledge of legio..., September 27, 2009

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.